Nitric oxide release: part II. Therapeutic applications.

A wide range of nitric oxide (NO)-releasing materials has emerged as potential therapeutics that exploit NO's vast biological roles. Macromolecular NO-releasing scaffolds are particularly promising due to their ability to store and deliver larger NO payloads in a more controlled and effective manner compared to low molecular weight NO donors. While a variety of scaffolds (e.g., particles, dendrimers, and polymers/films) have been cleverly designed, the ultimate clinical utility of most NO-releasing macromolecules remains unrealized. Although not wholly predictive of clinical success, in vitro and in vivo investigations have enabled a preliminary evaluation of the therapeutic potential of such materials. In this tutorial review, we review the application of macromolecular NO therapies for cardiovascular disease, cancer, bacterial infections, and wound healing.

[1]  M. Schoenfisch,et al.  Nitric oxide release: part I. Macromolecular scaffolds. , 2012, Chemical Society reviews.

[2]  M. Schoenfisch,et al.  Nitric oxide release: part III. Measurement and reporting. , 2012, Chemical Society reviews.

[3]  A. W. Carpenter,et al.  Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles. , 2011, ACS nano.

[4]  A. Coates,et al.  Novel classes of antibiotics or more of the same? , 2011, British journal of pharmacology.

[5]  S. Nair,et al.  Biomaterials based on chitin and chitosan in wound dressing applications. , 2011, Biotechnology advances.

[6]  D. Paterson,et al.  Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  M. Veerapandian,et al.  Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications , 2011, Applied Microbiology and Biotechnology.

[8]  R. Sotníková,et al.  Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions. , 2010, General physiology and biophysics.

[9]  M. Schoenfisch,et al.  Degradable nitric oxide-releasing biomaterials via post-polymerization functionalization of cross-linked polyesters. , 2010, Biomacromolecules.

[10]  A. S. Lynch,et al.  New antibiotic agents and approaches to treat biofilm-associated infections , 2010, Expert opinion on therapeutic patents.

[11]  S. Prakash,et al.  Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices , 2010, Applied Microbiology and Biotechnology.

[12]  I. Forsythe,et al.  Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia , 2010, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[13]  A. Goel,et al.  Nitric Oxide: Perspectives and Emerging Studies of a Well Known Cytotoxin , 2010, International journal of molecular sciences.

[14]  A. Seabra,et al.  Antibacterial nitric oxide-releasing polyester for the coating of blood-contacting artificial materials. , 2010, Artificial organs.

[15]  Paolo Pinton,et al.  Nanoscale particle therapies for wounds and ulcers. , 2010, Nanomedicine.

[16]  Jae Ho Shin,et al.  Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth. , 2010, Molecular pharmaceutics.

[17]  P. Mascharak,et al.  Eradication of Pathogenic Bacteria by Remote Delivery of NO via Light Triggering of Nitrosyl-Containing Materials , 2010 .

[18]  J. Lancaster,et al.  What Part of NO Don't You Understand? Some Answers to the Cardinal Questions in Nitric Oxide Biology* , 2010, The Journal of Biological Chemistry.

[19]  Melissa M. Reynolds,et al.  The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer. , 2010, Biomaterials.

[20]  H. Chakrapani,et al.  Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles. , 2010, Molecular pharmaceutics.

[21]  Jason R. Hickok,et al.  Nitric oxide and cancer therapy: the emperor has NO clothes. , 2010, Current pharmaceutical design.

[22]  D. Hirst,et al.  Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy. , 2010, Current pharmaceutical design.

[23]  Alexis D. Ostrowski,et al.  Metal complexes as photochemical nitric oxide precursors: potential applications in the treatment of tumors. , 2009, Dalton transactions.

[24]  M. Hashida,et al.  Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[25]  P. Mascharak,et al.  Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery. , 2009, Future medicinal chemistry.

[26]  Adam J Friedman,et al.  Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. , 2009, The Journal of investigative dermatology.

[27]  M. Schoenfisch,et al.  Nitric oxide-releasing S-nitrosothiol-modified xerogels. , 2009, Biomaterials.

[28]  D. McPherson,et al.  Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia. , 2009, Journal of the American College of Cardiology.

[29]  E. L. França,et al.  Nitric oxide, health and disease , 2009 .

[30]  T. O’Brien,et al.  Nitric oxide synthase gene therapy: progress and prospects , 2009, Expert opinion on biological therapy.

[31]  M. Schoenfisch,et al.  Morphological analysis of the antimicrobial action of nitric oxide on gram-negative pathogens using atomic force microscopy. , 2009, Acta biomaterialia.

[32]  M. Schoenfisch,et al.  Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. , 2009, Biomaterials.

[33]  S. Sortino,et al.  Nitric oxide photocaging platinum nanoparticles with anticancer potential , 2008 .

[34]  Mark H Schoenfisch,et al.  Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release. , 2008, Biomaterials.

[35]  H. Yasuda Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. , 2008, Nitric oxide : biology and chemistry.

[36]  B. Mayer,et al.  The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles , 2008, British journal of pharmacology.

[37]  A. Seabra,et al.  Nitric oxide donor improves healing if applied on inflammatory and proliferative phase. , 2008, The Journal of surgical research.

[38]  D. Hirst,et al.  Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions , 2008, The Journal of pharmacy and pharmacology.

[39]  L. Modolo,et al.  Wound healing agents: the role of natural and non-natural products in drug development. , 2008, Mini reviews in medicinal chemistry.

[40]  A. Seabra,et al.  Antithrombogenic polynitrosated polyester/poly(methyl methacrylate) blend for the coating of blood-contacting surfaces. , 2008, Artificial organs.

[41]  T. Fischer,et al.  S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles. , 2008, Biomacromolecules.

[42]  M. Schoenfisch,et al.  Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. , 2008, ACS nano.

[43]  B. Rigas Novel agents for cancer prevention based on nitric oxide. , 2007, Biochemical Society transactions.

[44]  J. Wallace Building a better aspirin: gaseous solutions to a century‐old problem , 2007, British journal of pharmacology.

[45]  M. R. Miller,et al.  Recent developments in nitric oxide donor drugs , 2007, British journal of pharmacology.

[46]  M. Hori,et al.  S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts. , 2007, Journal of molecular and cellular cardiology.

[47]  Simone Mocellin,et al.  Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities , 2007, Medicinal research reviews.

[48]  M. Schoenfisch,et al.  Antibacterial nitric oxide-releasing xerogels: cell viability and parallel plate flow cell adhesion studies. , 2007, Biomaterials.

[49]  Y. Miyamoto,et al.  S-Nitrosylation of Human Variant Albumin Liprizzi (R410C) Confers Potent Antibacterial and Cytoprotective Properties , 2007, Journal of Pharmacology and Experimental Therapeutics.

[50]  D. Hassett,et al.  Involvement of Nitric Oxide in Biofilm Dispersal of Pseudomonas aeruginosa , 2006, Journal of bacteriology.

[51]  M. Mulvany,et al.  Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung. , 2006, Cardiovascular drug reviews.

[52]  Manuela G. López,et al.  Preclinical profile of PF9404C, a nitric oxide donor with beta receptor blocking properties. , 2006, Cardiovascular drug reviews.

[53]  M. Hashida,et al.  Development of Polyethylene Glycol-Conjugated Poly-S-Nitrosated Serum Albumin, a Novel S-Nitrosothiol for Prolonged Delivery of Nitric Oxide in the Blood Circulation in Vivo , 2005, Journal of Pharmacology and Experimental Therapeutics.

[54]  P. Bottoni,et al.  Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential , 2005, Expert opinion on investigational drugs.

[55]  L. Keefer Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities. , 2005, Current topics in medicinal chemistry.

[56]  A. Ferro,et al.  Current status and future possibilities of nitric oxide-donor drugs: focus on S-nitrosothiols. , 2005, Mini-Reviews in Medical Chemistry.

[57]  M. Schoenfisch,et al.  Sol-gel derived potentiometric pH sensors. , 2005, Analytical chemistry.

[58]  Mary E. Robbins,et al.  Sol-gel derived nitric oxide-releasing oxygen sensors. , 2005, The Analyst.

[59]  Mary E. Robbins,et al.  Synthesis and characterization of nitric oxide-releasing sol-gel microarrays. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[60]  M. Schoenfisch,et al.  Antibacterial properties of nitric oxide-releasing sol-gel microarrays. , 2004, Biomacromolecules.

[61]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[62]  M. Schoenfisch,et al.  Poly(vinyl chloride)-coated sol-gels for studying the effects of nitric oxide release on bacterial adhesion. , 2004, Biomacromolecules.

[63]  M. Schoenfisch,et al.  Nitric oxide-releasing sol-gels as antibacterial coatings for orthopedic implants. , 2004, Biomaterials.

[64]  D. Townsend,et al.  Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. , 2004, Molecular pharmacology.

[65]  A. Barbul,et al.  Nitric Oxide and Wound Healing , 2004, World Journal of Surgery.

[66]  M. Schoenfisch,et al.  Antibacterial properties of nitric oxide-releasing sol-gels. , 2003, Journal of biomedical materials research. Part A.

[67]  Mary E. Robbins,et al.  Preparation of Nitric Oxide (NO)-Releasing Sol−Gels for Biomaterial Applications , 2003 .

[68]  R. Bartlett,et al.  Nitric oxide-releasing fumed silica particles: synthesis, characterization, and biomedical application. , 2003, Journal of the American Chemical Society.

[69]  C. Stratton Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance , 2003, Emerging infectious diseases.

[70]  Mark E Meyerhoff,et al.  In vivo biocompatibility and analytical performance of intravascular amperometric oxygen sensors prepared with improved nitric oxide-releasing silicone rubber coating. , 2002, Analytical chemistry.

[71]  Philip S Low,et al.  Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.

[72]  Jennifer L West,et al.  Effects of nitric oxide releasing poly(vinyl alcohol) hydrogel dressings on dermal wound healing in diabetic mice , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[73]  Robert J. Lee,et al.  Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. , 2002, Anticancer research.

[74]  D. Webb,et al.  Nitric oxide donor drugs: current status and future trends , 2002, Expert opinion on investigational drugs.

[75]  Ming Xian,et al.  Nitric oxide donors: chemical activities and biological applications. , 2002, Chemical reviews.

[76]  C. Stephens Microbiology: Breaking Down Biofilms , 2002, Current Biology.

[77]  J. Loscalzo,et al.  Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. , 2002, Circulation research.

[78]  M. Schoenfisch,et al.  Sol-gel derived nitric-oxide releasing materials that reduce bacterial adhesion. , 2001, Journal of the American Chemical Society.

[79]  Valdir C Colussi,et al.  Photodynamic therapy in oncology , 2001, Expert opinion on pharmacotherapy.

[80]  M. Meyerhoff,et al.  Improving the thromboresistivity of chemical sensors via nitric oxide release: fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters. , 2000, Analytical chemistry.

[81]  Z. Liu,et al.  Specificity of inducible nitric-oxide synthase inhibitors: prospects for their clinical therapy. , 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[82]  James B. Mitchell,et al.  The multifaceted roles of nitric oxide in cancer. , 1998, Carcinogenesis.

[83]  P. Vallance,et al.  Nitric Oxide 9 Years On , 1996, Journal of the Royal Society of Medicine.

[84]  K. M. Davies,et al.  Nitric oxide-releasing polymers containing the [N(O)NO]- group. , 1996, Journal of medicinal chemistry.

[85]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[86]  F. Murad,et al.  Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[87]  M. Schoenfisch,et al.  Reduced ischemia/reperfusion injury via glutathione-initiated nitric oxide-releasing dendrimers. , 2010, Nitric oxide : biology and chemistry.

[88]  Nick D. Tsihlis,et al.  Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. , 2008, Journal of vascular surgery.

[89]  M. Kibbe,et al.  Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. , 2008, Free radical biology & medicine.

[90]  S. Moncada,et al.  Inhibition of nitric oxide synthase as a potential therapeutic target. , 1999, Annual review of pharmacology and toxicology.